- FDA sends warning letter to Novo Nordisk over Ozempic, Wegovy side effects WPXI
- FDA Warns Novo Nordisk of Unreported Side Effects Tied to GLP-1 Patients WSJ
- Novo Hit With FDA Warning Letter for Unreported Ozempic Safety Signals BioSpace
- FDA scrutiny falls on Novo Nordisk, one of Triangle’s largest employers The Business Journals
- Novo Nordisk’s US headquarters under fire in latest FDA warning letter Fierce Pharma
